Cardiex (ASX:CDX) has announced their unaudited revenue for the September quarter, amounting to A$1.36 million.

This represents a year-on-year growth rate of 143%.

As part of an ongoing commitment to efficiency, the company is continuing to review its operations with an aim to reduce operating costs and streamline procedures.

Cardiex is a health technology company focused on heart health analytics.